Hideaki Nagai

Long-Term Low-Dose Administration of Erythromycin to Patients with Diffuse Panbronchiolitis

Hideaki Nagai, Harumi Shishido, Ryozo Yoneda et al. · Respiration · 2009 · 248 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases

Toshiyuki Harada, Yasushi Akiyama, Atsuyuki Kurashima et al. · Journal of Clinical Microbiology · 2012 · 172 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Assessment of sleep disturbance in lung cancer patients: Relationship between sleep disturbance and pain, fatigue, quality of life, and psychological distress

Mare Nishiura, Atsuhisa Tamura, Hideaki Nagai et al. · Palliative & Supportive Care · 2014 · 142 citations

Medicine, Oncology, Palliative Care +16

DOCK2 is involved in the host genetics and biology of severe COVID-19

Ho Namkoong, Ryuya Edahiro, Tomomi Takano et al. · Nature · 2022 · 97 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan

Lina Yi, Yuka Sasaki, Hideaki Nagai et al. · Scientific Reports · 2016 · 86 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17